{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T02:48:54Z","timestamp":1793155734526,"version":"4.5.0"},"reference-count":97,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,11]],"date-time":"2022-11-11T00:00:00Z","timestamp":1668124800000},"content-version":"am","delay-in-days":345,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["bmn.com","cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Pharmacological Sciences"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.tips.2021.10.001","type":"journal-article","created":{"date-parts":[[2021,11,5]],"date-time":"2021-11-05T10:29:03Z","timestamp":1636108143000},"page":"1082-1095","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":51,"title":["Cholesterol \u2013 the devil you know; ceramide \u2013 the devil you don\u2019t"],"prefix":"10.1016","volume":"42","author":[{"given":"Trevor S.","family":"Tippetts","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William L.","family":"Holland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4919-0592","authenticated-orcid":false,"given":"Scott A.","family":"Summers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tips.2021.10.001_bb0005","series-title":"The history of coronary heart disease","first-page":"227","author":"Leibowitz","year":"1970"},{"key":"10.1016\/j.tips.2021.10.001_bb0010","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.cell.2015.01.036","article-title":"A century of cholesterol and coronaries: from plaques to genes to statins","volume":"161","author":"Goldstein","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.tips.2021.10.001_bb0015","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1194\/jlr.R400012-JLR200","article-title":"Thematic review series: the pathogenesis of atherosclerosis. An interpretive history of the cholesterol controversy: part II: the early evidence linking hypercholesterolemia to coronary disease in humans","volume":"46","author":"Steinberg","year":"2005","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.tips.2021.10.001_bb0020","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/j.0954-6820.1938.tb19279.x","article-title":"Xanthomata, hypercholesterolemia, angina pectoris","volume":"95","author":"M\u00fcller","year":"1938","journal-title":"Acta Medica Scandinavica"},{"key":"10.1016\/j.tips.2021.10.001_bb0025","first-page":"93","article-title":"Apolipoprotein B: from editosome to proteasome","volume":"55","author":"Chan","year":"2000","journal-title":"Recent Prog. Horm. Res."},{"key":"10.1016\/j.tips.2021.10.001_bb0030","doi-asserted-by":"crossref","first-page":"33745","DOI":"10.1074\/jbc.M112.399725","article-title":"Loss- and gain-of-function PCSK9 variants: cleavage specificity, dominant negative effects, and low density lipoprotein receptor (LDLR) degradation","volume":"287","author":"Benjannet","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tips.2021.10.001_bb0035","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/S0021-9258(19)42998-0","article-title":"Regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity in cultured human fibroblasts. Comparison of cells from a normal subject and from a patient with homozygous familial hypercholesterolemia","volume":"249","author":"Brown","year":"1974","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tips.2021.10.001_bb0040","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1161\/ATVBAHA.108.179564","article-title":"The LDL receptor","volume":"29","author":"Goldstein","year":"2009","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.tips.2021.10.001_bb0045","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/0014-5793(76)80996-9","article-title":"Competitive inhibition of 3-hydroxy-3-methylglutaryl coenzyme A reductase by ML-236A and ML-236B fungal metabolites, having hypocholesterolemic activity","volume":"72","author":"Endo","year":"1976","journal-title":"FEBS Lett."},{"key":"10.1016\/j.tips.2021.10.001_bb0050","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S0140-6736(12)60367-5","article-title":"The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials","volume":"380","author":"Mihaylova","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.tips.2021.10.001_bb0055","doi-asserted-by":"crossref","DOI":"10.1111\/obr.13196","article-title":"Ancel Keys: The legacy of a giant in physiology, nutrition, and public health","volume":"22","author":"Montani","year":"2021","journal-title":"Obes. Rev."},{"key":"10.1016\/j.tips.2021.10.001_bb0060","first-page":"155","article-title":"Serum cholesterol in cross-cultural perspective. The Seven Countries Study","volume":"54","author":"Kromhout","year":"1999","journal-title":"Acta Cardiol."},{"key":"10.1016\/j.tips.2021.10.001_bb0065","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1093\/eurheartj\/ehw148","article-title":"Plasma ceramides predict cardiovascular death in patients with stable coronary artery disease and acute coronary syndromes beyond LDL-cholesterol","volume":"37","author":"Laaksonen","year":"2016","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.tips.2021.10.001_bb0070","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.1161\/ATVBAHA.116.307497","article-title":"Circulating ceramides predict cardiovascular outcomes in the population-based FINRISK 2002 Cohort","volume":"36","author":"Havulinna","year":"2016","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.tips.2021.10.001_bb0075","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1194\/jlr.P081281","article-title":"Plasma concentrations of molecular lipid species predict long-term clinical outcome in coronary artery disease patients","volume":"59","author":"Anroedh","year":"2018","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.tips.2021.10.001_bb0080","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1093\/eurheartj\/ehz387","article-title":"Development and validation of a ceramide- and phospholipid-based cardiovascular risk estimation score for coronary artery disease patients","volume":"41","author":"Hilvo","year":"2020","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.tips.2021.10.001_bb0085","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1007\/s00125-018-4590-6","article-title":"Ceramide stearic to palmitic acid ratio predicts incident diabetes","volume":"61","author":"Hilvo","year":"2018","journal-title":"Diabetologia"},{"key":"10.1016\/j.tips.2021.10.001_bb0090","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.atherosclerosis.2018.01.004","article-title":"PCSK9 inhibition alters the lipidome of plasma and lipoprotein fractions","volume":"269","author":"Hilvo","year":"2018","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.tips.2021.10.001_bb0095","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1194\/jlr.M092809","article-title":"New evidence from plasma ceramides links apoE polymorphism to greater risk of coronary artery disease in Finnish adults","volume":"60","author":"Karjalainen","year":"2019","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.tips.2021.10.001_bb0100","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.diabet.2019.07.006","article-title":"Associations between specific plasma ceramides and severity of coronary-artery stenosis assessed by coronary angiography","volume":"46","author":"Mantovani","year":"2020","journal-title":"Diabetes Metab."},{"key":"10.1016\/j.tips.2021.10.001_bb0105","doi-asserted-by":"crossref","first-page":"2854","DOI":"10.1161\/ATVBAHA.118.311927","article-title":"Association of plasma ceramides with myocardial perfusion in patients with coronary artery disease undergoing stress myocardial perfusion scintigraphy","volume":"38","author":"Mantovani","year":"2018","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.tips.2021.10.001_bb0110","doi-asserted-by":"crossref","first-page":"115160","DOI":"10.1016\/j.bone.2019.115160","article-title":"Lipidomic architecture shared by subclinical markers of osteoporosis and atherosclerosis: the cardiovascular risk in Young Finns Study","volume":"131","author":"Mishra","year":"2020","journal-title":"Bone"},{"key":"10.1016\/j.tips.2021.10.001_bb0115","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.chembiol.2018.10.008","article-title":"High-throughput plasma lipidomics: detailed mapping of the associations with cardiometabolic risk factors","volume":"26","author":"Huynh","year":"2019","journal-title":"Cell Chem. Biol."},{"key":"10.1016\/j.tips.2021.10.001_bb0120","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1093\/jn\/nxz259","article-title":"Plasma ceramide species are associated with diabetes risk in participants of the Strong Heart Study","volume":"150","author":"Fretts","year":"2020","journal-title":"J. Nutr."},{"key":"10.1016\/j.tips.2021.10.001_bb0125","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.ebiom.2018.12.046","article-title":"Circulating sphingolipids, fasting glucose, and impaired fasting glucose: The Strong Heart Family Study","volume":"41","author":"Jensen","year":"2019","journal-title":"EBioMedicine"},{"key":"10.1016\/j.tips.2021.10.001_bb0130","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.118.005708","article-title":"Plasma ceramides and sphingomyelins in relation to heart failure risk","volume":"12","author":"Lemaitre","year":"2019","journal-title":"Circ. Heart Fail."},{"key":"10.1016\/j.tips.2021.10.001_bb0135","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.2337\/db17-1449","article-title":"Circulating sphingolipids, insulin, HOMA-IR and HOMA-B: the Strong Heart Family Study","volume":"7","author":"Lemaitre","year":"2018","journal-title":"Diabetes"},{"key":"10.1016\/j.tips.2021.10.001_bb0140","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.2337\/dc18-0071","article-title":"Saturated fat is more metabolically harmful for the human liver than unsaturated fat or simple sugars","volume":"41","author":"Luukkonen","year":"2018","journal-title":"Diabetes Care"},{"key":"10.1016\/j.tips.2021.10.001_bb0145","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1016\/j.celrep.2017.02.019","article-title":"Plasma dihydroceramides are diabetes susceptibility biomarker candidates in mice and humans","volume":"18","author":"Wigger","year":"2017","journal-title":"Cell Rep."},{"key":"10.1016\/j.tips.2021.10.001_bb0150","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1172\/JCI131838","article-title":"Machine learning reveals serum sphingolipids as cholesterol-independent biomarkers of coronary artery disease","volume":"130","author":"Poss","year":"2020","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.tips.2021.10.001_bb0155","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.96203","article-title":"Increased de novo ceramide synthesis and accumulation in failing myocardium","volume":"2","author":"Ji","year":"2017","journal-title":"JCI Insight"},{"key":"10.1016\/j.tips.2021.10.001_bb0160","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/j.jhep.2016.01.002","article-title":"Hepatic ceramides dissociate steatosis and insulin resistance in patients with non-alcoholic fatty liver disease","volume":"64","author":"Luukkonen","year":"2016","journal-title":"J. Hepatol."},{"key":"10.1016\/j.tips.2021.10.001_bb0165","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.2337\/db07-0111","article-title":"Adipose tissue inflammation and increased ceramide content characterize subjects with high liver fat content independent of obesity","volume":"56","author":"Kolak","year":"2007","journal-title":"Diabetes"},{"key":"10.1016\/j.tips.2021.10.001_bb0170","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.cmet.2014.08.002","article-title":"Obesity-induced CerS6-dependent C16:0 ceramide production promotes weight gain and glucose intolerance","volume":"20","author":"Turpin","year":"2014","journal-title":"Cell Metab."},{"key":"10.1016\/j.tips.2021.10.001_bb0175","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/j.cmet.2016.10.002","article-title":"Adipocyte ceramides regulate subcutaneous adipose browning, inflammation, and metabolism","volume":"24","author":"Chaurasia","year":"2016","journal-title":"Cell Metab."},{"key":"10.1016\/j.tips.2021.10.001_bb0180","doi-asserted-by":"crossref","first-page":"80","DOI":"10.2337\/db09-0988","article-title":"Insulin resistance is associated with higher intramyocellular triglycerides in type I but not type II myocytes concomitant with higher ceramide content","volume":"59","author":"Coen","year":"2010","journal-title":"Diabetes"},{"key":"10.1016\/j.tips.2021.10.001_bb0185","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.tem.2012.05.009","article-title":"Role of intramyocelluar lipids in human health","volume":"23","author":"Coen","year":"2012","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.tips.2021.10.001_bb0190","doi-asserted-by":"crossref","first-page":"2362","DOI":"10.1002\/oby.20381","article-title":"Reduced skeletal muscle oxidative capacity and elevated ceramide but not diacylglycerol content in severe obesity","volume":"21","author":"Coen","year":"2013","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.tips.2021.10.001_bb0195","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1007\/s00125-011-2065-0","article-title":"Effects of weight loss and exercise on insulin resistance, and intramyocellular triacylglycerol, diacylglycerol and ceramide","volume":"54","author":"Dube","year":"2011","journal-title":"Diabetologia"},{"key":"10.1016\/j.tips.2021.10.001_bb0200","doi-asserted-by":"crossref","first-page":"25","DOI":"10.2337\/diabetes.53.1.25","article-title":"Ceramide content is increased in skeletal muscle from obese insulin-resistant humans","volume":"53","author":"Adams","year":"2004","journal-title":"Diabetes"},{"key":"10.1016\/j.tips.2021.10.001_bb0205","doi-asserted-by":"crossref","first-page":"3171","DOI":"10.1113\/JP271677","article-title":"CrossTalk opposing view: intramyocellular ceramide accumulation does not modulate insulin resistance","volume":"594","author":"Petersen","year":"2016","journal-title":"J. Physiol."},{"key":"10.1016\/j.tips.2021.10.001_bb0210","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.2337\/dc17-1318","article-title":"Specific hepatic sphingolipids relate to insulin resistance, oxidative stress, and inflammation in nonalcoholic steatohepatitis","volume":"41","author":"Apostolopoulou","year":"2018","journal-title":"Diabetes Care"},{"key":"10.1016\/j.tips.2021.10.001_bb0215","doi-asserted-by":"crossref","DOI":"10.1136\/bmjdrc-2020-001860","article-title":"Role of ceramide-to-dihydroceramide ratios for insulin resistance and non-alcoholic fatty liver disease in humans","volume":"8","author":"Apostolopoulou","year":"2020","journal-title":"BMJ Open Diabetes Res. Care"},{"key":"10.1016\/j.tips.2021.10.001_bb0220","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.cmet.2017.12.003","article-title":"Could ceramides become the new cholesterol?","volume":"27","author":"Summers","year":"2018","journal-title":"Cell Metab."},{"key":"10.1016\/j.tips.2021.10.001_bb0225","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1126\/science.8456305","article-title":"Programmed cell death induced by ceramide","volume":"259","author":"Obeid","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.tips.2021.10.001_bb0230","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1126\/science.8424175","article-title":"Activation of the sphingomyelin signaling pathway in intact EL4 cells and in a cell-free system by IL-1 beta","volume":"259","author":"Mathias","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.tips.2021.10.001_bb0235","doi-asserted-by":"crossref","first-page":"16880","DOI":"10.1016\/S0021-9258(17)44844-7","article-title":"1,2-diacylglycerol and ceramide levels in insulin-resistant tissues of the rat in vivo","volume":"265","author":"Turinsky","year":"1990","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tips.2021.10.001_bb0240","doi-asserted-by":"crossref","first-page":"10878","DOI":"10.1073\/pnas.91.23.10878","article-title":"Beta-cell lipotoxicity in the pathogenesis of non-insulin-dependent diabetes mellitus of obese rats: impairment in adipocyte-beta-cell relationships","volume":"91","author":"Lee","year":"1994","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tips.2021.10.001_bb0245","doi-asserted-by":"crossref","first-page":"5159","DOI":"10.1210\/en.2003-0870","article-title":"Minireview: weapons of lean body mass destruction: the role of ectopic lipids in the metabolic syndrome","volume":"144","author":"Unger","year":"2003","journal-title":"Endocrinology"},{"key":"10.1016\/j.tips.2021.10.001_bb0250","doi-asserted-by":"crossref","first-page":"5457","DOI":"10.1128\/MCB.18.9.5457","article-title":"Regulation of insulin-stimulated glucose transporter GLUT4 translocation and Akt kinase activity by ceramide","volume":"18","author":"Summers","year":"1998","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.tips.2021.10.001_bb0255","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.cmet.2007.01.002","article-title":"Inhibition of ceramide synthesis ameliorates glucocorticoid-, saturated-fat-, and obesity-induced insulin resistance","volume":"5","author":"Holland","year":"2007","journal-title":"Cell Metab."},{"key":"10.1016\/j.tips.2021.10.001_bb0260","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1126\/science.aav3722","article-title":"Targeting a ceramide double bond improves insulin resistance and hepatic steatosis","volume":"365","author":"Chaurasia","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.tips.2021.10.001_bb0265","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/1471-2121-9-45","article-title":"Uptake of long chain fatty acids is regulated by dynamic interaction of FAT\/CD36 with cholesterol\/sphingolipid enriched microdomains (lipid rafts)","volume":"9","author":"Ehehalt","year":"2008","journal-title":"BMC Cell Biol."},{"key":"10.1016\/j.tips.2021.10.001_bb0270","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.tem.2015.07.006","article-title":"Ceramides \u2013 lipotoxic inducers of metabolic disorders","volume":"26","author":"Chaurasia","year":"2015","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.tips.2021.10.001_bb0275","doi-asserted-by":"crossref","first-page":"4222","DOI":"10.1172\/JCI57144","article-title":"Ceramides as modulators of cellular and whole-body metabolism","volume":"121","author":"Bikman","year":"2011","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.tips.2021.10.001_bb0280","doi-asserted-by":"crossref","first-page":"42936","DOI":"10.1074\/jbc.M307228200","article-title":"Early embryonic lethality caused by targeted disruption of the 3-hydroxy-3-methylglutaryl-CoA reductase gene","volume":"278","author":"Ohashi","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tips.2021.10.001_bb0285","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3109\/03602532.2010.540580","article-title":"Defects in cholesterol synthesis genes in mouse and in humans: lessons for drug development and safer treatments","volume":"43","author":"Horvat","year":"2011","journal-title":"Drug Metab. Rev."},{"key":"10.1016\/j.tips.2021.10.001_bb0290","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1086\/323473","article-title":"Mutations in the 3beta-hydroxysterol Delta24-reductase gene cause desmosterolosis, an autosomal recessive disorder of cholesterol biosynthesis","volume":"69","author":"Waterham","year":"2001","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.tips.2021.10.001_bb0295","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1126\/science.1090776","article-title":"Generation of viable cholesterol-free mice","volume":"302","author":"Wechsler","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.tips.2021.10.001_bb0300","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.pharmthera.2010.03.007","article-title":"Perspectives of the non-statin hypolipidemic agents","volume":"127","author":"Rozman","year":"2010","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.tips.2021.10.001_bb0305","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1538\/expanim.58.515","article-title":"Analysis of development of lesions in mice with serine palmitoyltransferase (SPT) deficiency-Sptlc2 conditional knockout mice","volume":"58","author":"Ohta","year":"2009","journal-title":"Exp. Anim."},{"key":"10.1016\/j.tips.2021.10.001_bb0310","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1172\/JCI124159","article-title":"DEGS1-associated aberrant sphingolipid metabolism impairs nervous system function in humans","volume":"129","author":"Karsai","year":"2019","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.tips.2021.10.001_bb0315","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1038\/s41431-019-0444-z","article-title":"DEGS1 variant causes neurological disorder","volume":"27","author":"Dolgin","year":"2019","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.tips.2021.10.001_bb0320","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1172\/JCI123959","article-title":"Loss of the sphingolipid desaturase DEGS1 causes hypomyelinating leukodystrophy","volume":"129","author":"Pant","year":"2019","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.tips.2021.10.001_bb0325","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.cmet.2015.06.007","article-title":"Targeted induction of ceramide degradation leads to improved systemic metabolism and reduced hepatic steatosis","volume":"22","author":"Xia","year":"2015","journal-title":"Cell Metab."},{"key":"10.1016\/j.tips.2021.10.001_bb0330","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.atherosclerosis.2007.09.018","article-title":"Ceramide: a common pathway for atherosclerosis?","volume":"196","author":"Bismuth","year":"2008","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.tips.2021.10.001_bb0335","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1161\/01.ATV.18.10.1523","article-title":"Sphingolipids in atherosclerosis and vascular biology","volume":"18","author":"Chatterjee","year":"1998","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.tips.2021.10.001_bb0340","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S1050-1738(01)00143-8","article-title":"Sphingomyelinase activity of LDL: a link between atherosclerosis, ceramide, and apoptosis?","volume":"12","author":"Kinnunen","year":"2002","journal-title":"Trends Cardiovasc. Med."},{"key":"10.1016\/j.tips.2021.10.001_bb0345","doi-asserted-by":"crossref","first-page":"225701","DOI":"10.1103\/PhysRevLett.122.225701","article-title":"Phase transitions of hybrid perovskites simulated by machine-learning force fields trained on the fly with Bayesian inference","volume":"122","author":"Jinnouchi","year":"2019","journal-title":"Phys. Rev. Lett."},{"key":"10.1016\/j.tips.2021.10.001_bb0350","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/nm.2277","article-title":"Receptor-mediated activation of ceramidase activity initiates the pleiotropic actions of adiponectin","volume":"17","author":"Holland","year":"2011","journal-title":"Nat. Med."},{"key":"10.1016\/j.tips.2021.10.001_bb0355","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/nature21714","article-title":"Structural insights into adiponectin receptors suggest ceramidase activity","volume":"544","author":"Vasiliauskait\u00e9-Brooks","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.tips.2021.10.001_bb0360","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.molmet.2017.01.002","article-title":"Inducible overexpression of adiponectin receptors highlight the roles of adiponectin-induced ceramidase signaling in lipid and glucose homeostasis","volume":"6","author":"Holland","year":"2017","journal-title":"Mol. Metab."},{"key":"10.1016\/j.tips.2021.10.001_bb0365","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.cmet.2014.09.015","article-title":"CerS2 haploinsufficiency inhibits \u03b2-oxidation and confers susceptibility to diet-induced steatohepatitis and insulin resistance","volume":"20","author":"Raichur","year":"2014","journal-title":"Cell Metab."},{"key":"10.1016\/j.tips.2021.10.001_bb0370","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.isci.2018.10.019","article-title":"The mevalonate pathway is indispensable for adipocyte survival","volume":"9","author":"Yeh","year":"2018","journal-title":"iScience"},{"key":"10.1016\/j.tips.2021.10.001_bb0375","doi-asserted-by":"crossref","first-page":"101145","DOI":"10.1016\/j.molmet.2020.101145","article-title":"Ceramides are necessary and sufficient for diet-induced impairment of thermogenic adipocytes","volume":"45","author":"Chaurasia","year":"2021","journal-title":"Mol. Metab."},{"key":"10.1016\/j.tips.2021.10.001_bb0380","doi-asserted-by":"crossref","first-page":"3929","DOI":"10.1074\/jbc.M116.756460","article-title":"De novo sphingolipid biosynthesis is required for adipocyte survival and metabolic homeostasis","volume":"292","author":"Alexaki","year":"2017","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tips.2021.10.001_bb0385","doi-asserted-by":"crossref","first-page":"2596","DOI":"10.2337\/db16-1232","article-title":"Adipocyte-specific deficiency of de novo sphingolipid biosynthesis leads to lipodystrophy and insulin resistance","volume":"66","author":"Lee","year":"2017","journal-title":"Diabetes"},{"key":"10.1016\/j.tips.2021.10.001_bb0390","doi-asserted-by":"crossref","first-page":"18429","DOI":"10.1074\/jbc.M111.296947","article-title":"Cardiomyocyte specific deficiency of serine palmitoyltransferase subunit 2 reduces ceramide but leads to cardiac dysfunction","volume":"287","author":"Lee","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tips.2021.10.001_bb0395","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1194\/jlr.M800147-JLR200","article-title":"Ceramide is a cardiotoxin in lipotoxic cardiomyopathy","volume":"49","author":"Park","year":"2008","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.tips.2021.10.001_bb0400","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1161\/CIRCULATIONAHA.120.047420","article-title":"Cardiomyocyte kruppel-like factor 5 promotes de novo ceramide biosynthesis and contributes to eccentric remodeling in ischemic cardiomyopathy","volume":"143","author":"Hoffman","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.tips.2021.10.001_bb0405","doi-asserted-by":"crossref","first-page":"2821","DOI":"10.1001\/jama.291.23.2821","article-title":"Pharmacogenetic study of statin therapy and cholesterol reduction","volume":"291","author":"Chasman","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.tips.2021.10.001_bb0410","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0140-6736(14)61183-1","article-title":"HMG-coenzyme A reductase inhibition, type 2 diabetes, and bodyweight: evidence from genetic analysis and randomised trials","volume":"385","author":"Swerdlow","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.tips.2021.10.001_bb0415","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.omtm.2017.05.003","article-title":"Lentivector iterations and pre-clinical scale-up\/toxicity testing: targeting mobilized CD34(+) cells for correction of Fabry disease","volume":"5","author":"Huang","year":"2017","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.tips.2021.10.001_bb0420","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1515\/hsz-2014-0290","article-title":"The molecular medicine of acid ceramidase","volume":"396","author":"Frohbergh","year":"2015","journal-title":"Biol. Chem."},{"key":"10.1016\/j.tips.2021.10.001_bb0425","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002383","article-title":"Impact of common genetic determinants of hemoglobin A1c on type 2 diabetes risk and diagnosis in ancestrally diverse populations: a transethnic genome-wide meta-analysis","volume":"14","author":"Wheeler","year":"2017","journal-title":"PLoS Med."},{"key":"10.1016\/j.tips.2021.10.001_bb0430","doi-asserted-by":"crossref","DOI":"10.1093\/ndt\/gfv087","article-title":"Genome-wide studies to identify risk factors for kidney disease with a focus on patients with diabetes","volume":"30","author":"Regele","year":"2015","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.tips.2021.10.001_bb0435","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0106631","article-title":"A gene variant in CERS2 is associated with rate of increase in albuminuria in patients with diabetes from ONTARGET and TRANSCEND","volume":"9","author":"Shiffman","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.tips.2021.10.001_bb0440","doi-asserted-by":"crossref","first-page":"e3098","DOI":"10.1210\/clinem\/dgab155","article-title":"Characterizing a common CERS2 polymorphism in a mouse model of metabolic disease and in subjects from the Utah CAD study","volume":"106","author":"Nicholson","year":"2021","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.tips.2021.10.001_bb0445","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1194\/jlr.P094433","article-title":"Rare DEGS1 variant significantly alters de novo ceramide synthesis pathway","volume":"60","author":"Blackburn","year":"2019","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.tips.2021.10.001_bb0455","doi-asserted-by":"crossref","first-page":"E45","DOI":"10.1210\/jc.2013-2559","article-title":"Molecular lipids identify cardiovascular risk and are efficiently lowered by simvastatin and PCSK9 deficiency","volume":"99","author":"Tarasov","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.tips.2021.10.001_bb0460","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.plipres.2010.03.003","article-title":"Sterols and sphingolipids: dynamic duo or partners in crime?","volume":"49","author":"Gulati","year":"2010","journal-title":"Prog. Lipid Res."},{"key":"10.1016\/j.tips.2021.10.001_bb0465","first-page":"154","article-title":"Sphingolipid organization in the plasma membrane and the mechanisms that influence it","volume":"4","author":"Kraft","year":"2016","journal-title":"Front Cell Dev. Biol."},{"key":"10.1016\/j.tips.2021.10.001_bb0470","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.jcis.2005.06.043","article-title":"Interactions between sphingomyelin and cholesterol in low density lipoproteins and model membranes","volume":"293","author":"Guarino","year":"2006","journal-title":"J. Colloid Interface Sci."},{"key":"10.1016\/j.tips.2021.10.001_bb0475","first-page":"445","article-title":"Sphingomyelin synthase-related protein SMSr is a suppressor of ceramide-induced mitochondrial apoptosis","volume":"127","author":"Tafesse","year":"2014","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.tips.2021.10.001_bb0480","first-page":"158489","article-title":"The role of ceramide in regulating endoplasmic reticulum function","volume":"2020","author":"Zelnik","year":"1865","journal-title":"Biochim. Biophys. Acta Mol. Cell Biol. Lipids"},{"key":"10.1016\/j.tips.2021.10.001_bb0485","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s10863-014-9592-6","article-title":"Mitochondrial cholesterol: mechanisms of import and effects on mitochondrial function","volume":"48","author":"Martin","year":"2016","journal-title":"J. Bioenerg. Biomembr."},{"key":"10.1016\/j.tips.2021.10.001_bb0490","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1016\/j.cell.2019.05.008","article-title":"CerS6-derived sphingolipids interact with Mff and promote mitochondrial fragmentation in obesity","volume":"177","author":"Hammerschmidt","year":"2019","journal-title":"Cell"}],"container-title":["Trends in Pharmacological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165614721001905?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165614721001905?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T09:12:14Z","timestamp":1759050734000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165614721001905"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":97,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["S0165614721001905"],"URL":"https:\/\/doi.org\/10.1016\/j.tips.2021.10.001","relation":{},"ISSN":["0165-6147"],"issn-type":[{"value":"0165-6147","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cholesterol \u2013 the devil you know; ceramide \u2013 the devil you don\u2019t","name":"articletitle","label":"Article Title"},{"value":"Trends in Pharmacological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tips.2021.10.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}